Pacira BioSciences' Enterprise Value rose 4571.87% to -$246.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$246.3 million, marking a year-over-year increase of 4571.87%. This contributed to the annual value of -$484.6 million for FY2024, which is 7395.84% down from last year.
Latest data reveals that Pacira BioSciences reported Enterprise Value of -$246.3 million as of Q3 2025, which was up 4571.87% from -$445.9 million recorded in Q2 2025.
Pacira BioSciences' Enterprise Value's 5-year high stood at -$174.0 million during Q1 2023, with a 5-year trough of -$693.9 million in Q3 2021.
Moreover, its 5-year median value for Enterprise Value was -$404.2 million (2024), whereas its average is -$407.1 million.
Per our database at Business Quant, Pacira BioSciences' Enterprise Value plummeted by 9786.13% in 2021 and then soared by 6152.12% in 2023.
Over the past 5 years, Pacira BioSciences' Enterprise Value (Quarter) stood at -$656.4 million in 2021, then soared by 56.03% to -$288.7 million in 2022, then rose by 3.49% to -$278.6 million in 2023, then tumbled by 73.96% to -$484.6 million in 2024, then surged by 49.17% to -$246.3 million in 2025.
Its Enterprise Value was -$246.3 million in Q3 2025, compared to -$445.9 million in Q2 2025 and -$493.6 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value